EODData

MEMBERSHIP REGISTER LOG IN

LSE, 0QNA: Basilea Pharmaceutica AG

11 Nov 2025
LAST:

46.10

CHANGE:
 0.60		OPEN:
45.95		HIGH:
46.30		ASK:
0.00		VOLUME:
6.3K
CHG(%):
1.32		PREV:
45.50		LOW:
45.87		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
11 Nov 2545.9546.3045.8746.106.3K
10 Nov 2545.4845.7045.4545.5064
07 Nov 2544.7344.9044.7044.702.7K
06 Nov 2545.1045.4044.8045.401.9K
05 Nov 2545.5546.0045.5546.00218
04 Nov 2546.6846.6846.4546.656.3K
03 Nov 2546.4046.4045.2545.873.0K
31 Oct 2546.3046.6046.2046.502.0K
30 Oct 2545.9546.2545.8546.252.2K
29 Oct 2546.2046.2046.2046.201.9K

COMPANY PROFILE

Name:Basilea Pharmaceutica AG
About:Basilea Pharmaceutica AG is a Swiss commercial-stage biotech company focused on developing and commercializing treatments for severe bacterial and fungal infections. The company offers Cresemba (isavuconazole), an intravenous and oral antifungal for the treatment of invasive aspergillosis and mucormycosis; and Zevtera (ceftobiprole), an antibiotic for the treatment of pneumonia, Staphylococcus aureus bacteremia (SAB), and acute bacterial skin and skin structure infections (ABSSSI). The company also has a clinical-stage pipeline of anti-infective assets that include fosmanogepix, a broad-spectrum antifungal in phase 3 development for invasive mold and yeast infections; ceftibuten-ledaborbactam, a phase 3 - ready oral antibiotic for the treatment of complicated urinary tract infections (cUTI); BAL2062, a candidate for invasive aspergillosis currently advancing toward phase 2 clinical development; and BAL2420, a preclinical-stage antibiotic targeting severe Enterobacteriaceae infections. Basilea Pharmaceutica AG was founded in 2000 and is headquartered in Allschwil, Switzerland.
Address:Hegenheimermattweg 167b, Allschwil, Switzerland, 4123
Website:https://www.basilea.com

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:51.83 
PEG Ratio:-1.04 
Price to Sales:2.10 
Price to Book:5.46 
Profit Margin:0.31 
Operating Margin:0.23 
Return on Assets:0.22 
Return on Equity:1.21 
EPS Ratio:-0.59 
Revenue:236.21M 
EBITDA:78.07M 
Shares:10.87M 
Market Cap:501.08M 

TECHNICAL INDICATORS

MA5:45.541.2%
MA10:45.920.4%
MA20:47.052.1%
MA50:47.202.4%
MA100:49.036.4%
MA200:47.001.9%
STO9:70.84
STO14:33.31
RSI14:34.34 
WPR14:-65.56
MTM14:-2.66
ROC14:-0.05 
ATR:0.84 
Week High:46.681.2%
Week Low:44.703.1%
Month High:49.357.1%
Month Low:44.701.9%
Year High:59.5529.2%
Year Low:38.6019.4%
Volatility:19.15 

RECENT DIVIDENDS

Date Amount
15 Dec 2022$0.10
14 Sep 2022$0.10
15 Jun 2022$0.10
16 Mar 2022$0.10
15 Dec 2021$0.10
14 Sep 2021$0.10
15 Jun 2021$0.10
16 Mar 2021$0.10
17 Nov 2020$0.10
17 Aug 2020$0.10